Participating in WHX Dubai – World Health Expo means positioning oneself at the heart of the dynamics redefining the global healthcare sector. It is not simply one of the largest international exhibitions dedicated to medical technologies, but a privileged observatory on the future directions of healthcare innovation.
For Elemaster Group, being present in Dubai was not merely an exhibition showcase. It was a strategic decision, consistent with a path of continuous internationalisation and with the determination to be present where innovation is born, presented and transformed into tangible reality.
The following reflections are based on insights shared by Fabrizio Tornetta, Managing Director of Elemaster Germany, who represented the Group during WHX Dubai 2026 and provided a direct perspective from the exhibition floor.
Why WHX Dubai is a strategic hub for global healthcare innovation
WHX today represents a global platform where companies, institutions, investors and innovators from every continent converge. Its geographical location, in a strategic hub such as Dubai, perfectly reflects the evolution of the medical market: increasingly international, interconnected and oriented towards new growth areas.
For Elemaster, a leader in the most advanced technological niches of medical electronics, being present in this context means:
- identifying emerging trends before they become mainstream
- consolidating relationships with international partners
- evaluating regional expansion opportunities
- understanding how global demand is evolving in terms of technology, compliance and scalability
It is not about “following” the market, but about actively contributing to shaping it.
Emerging needs in the international medical device market
Dialogue with international stakeholders confirmed a clear direction: the healthcare sector increasingly demands advanced, high-complexity technologies, far removed from commodity or disposable segments.
The requirements emerging revolve around medical devices that are:
- high in technological content
- characterised by medium to low production volumes
- strongly integrated between electronics, software and intelligent systems
- designed for global markets with stringent regulatory frameworks
In this scenario, the ability to offer not only manufacturing, but technological partnership from the earliest R&D phases becomes central.
This is precisely where Elemaster’s distinctive positioning lies.
Scalability and modularity in medical device development
A particularly relevant insight that emerged at WHX concerns the growing need for scalability and modularity within product portfolios.
Many operators no longer wish to start from scratch with each new project. Instead, they seek partners capable of:
- intervening on existing platforms
- optimising established architectures
- making systems more modular
- accelerating regional and technological expansion
- reducing time-to-market and development costs
Modularity therefore becomes a strategic lever: evolving an existing product rather than replacing it, improving performance and compliance while maintaining a solid foundation.
In this context, Elemaster’s ability to operate throughout the entire product lifecycle represents a concrete competitive advantage.
Cybersecurity, AI and IoT: the converging forces reshaping healthcare electronics
Among the most evident macro-trends emerging during WHX Dubai, three technological forces clearly stand out: cybersecurity, artificial intelligence and the growing centrality of connected ecosystems.
Cybersecurity in medical devices and connected healthcare systems
With the increasing interconnection of medical devices, data protection and system integrity have become structural design requirements. Security is no longer an accessory layer added at the end of development, but an architectural principle embedded from the earliest stages of system engineering.
Artificial Intelligence in medical devices and healthcare electronics
AI is reshaping diagnostic devices, monitoring systems and therapeutic solutions, enabling predictive analytics, workflow optimisation and higher clinical precision. However, its effective integration requires robust hardware-software architectures and full regulatory alignment.
IoT in medical technology and connected medical ecosystems
Beyond AI and cybersecurity, another decisive shift concerns the expansion of IoT in medical technology. Devices are no longer isolated units, but nodes within interconnected platforms where the real value increasingly lies in data generation, analysis and interoperability.
In this scenario, competitive advantage no longer derives solely from the device itself, but from the ability to design secure, scalable and intelligent systems capable of operating within complex digital healthcare infrastructures.
As discussed in Elemaster’s reflections on IoT in medical technology, when value moves from hardware to data, engineering must evolve accordingly. This transition requires industrial partners able to integrate hardware, firmware, cloud connectivity, cybersecurity and compliance into a single coherent ecosystem.
In all three dimensions, effective implementation depends on cross-disciplinary expertise and on an industrial structure capable of combining advanced engineering with regulatory awareness and lifecycle management.
One Stop Shop partner for medical device design, production and lifecycle management
In the medical sector, regulatory and technological complexity requires integrated management. Elemaster positions itself as a One Stop Shop and strategic industrial partner, supporting customers:
- from research and development
- through design and prototyping
- to series production
- up to service and after-sales
- well beyond the end of the product lifecycle
Support in regulatory compliance, including consultancy in the field of MDR (Medical Device Regulation), represents a distinctive element. It is not merely about building a device, but about supporting its market introduction in full compliance with complex standards and certifications.
The ability to integrate custom components and manage obsolescence further strengthens this role.
As highlighted by Fabrizio Tornetta, Managing Director of Elemaster Germany, operating in the medical sector requires not only advanced engineering capabilities, but also the ability to navigate complex regulatory frameworks with speed and precision.
Few organisations are able to combine:
- proximity to the customer
- high technological expertise
- advanced vertical integration
- structured international presence
Medical device compliance and MDR support as competitive advantage
The experience gained in the medical sector has already demonstrated the robustness of the Elemaster model.
An emblematic example is represented by the MVM project during the pandemic, which obtained emergency FDA certification in the shortest time recorded. A result that testifies to the ability to operate with speed, technical rigour and full regulatory compliance in highly critical contexts.
This type of performance consolidates the Group’s reputation as a reliable partner for multinational companies operating in their respective sectors.
Elemaster Germany and International Design Centers: enabling global expansion
In the path of internationalisation, a key role is played by Elemaster Germany, an integral part of the International Design Centers, alongside Eletech, the lead company of the IDCs, R&D division of Elemaster Group.
The German site operates as:
- an R&D and PCB layout centre
- a hub for local prototyping and small series production
- a gateway to the German and Northern European markets
Thanks to a consolidated portfolio of contacts with German and international multinationals, Elemaster Germany enables the Group to activate initial R&D and prototyping projects that can subsequently evolve into series production and full lifecycle management on a global scale, in synergy with the broader engineering and industrial capabilities of the IDCs.
In this context, Elemaster Germany plays a strategic and integrative role within the International Design Centers (IDCs), complementing Eletech’s technological leadership and reinforcing the Group’s distributed R&D structure.
With engineering expertise in R&D and PCB layout, as well as the capability to produce prototypes and small series locally, Elemaster Germany acts as a gateway to the German and Northern European markets.
Its established network of multinational contacts enables the Group to initiate R&D and prototyping collaborations that can later evolve into full lifecycle industrialisation within the broader Elemaster ecosystem.
It is an integrated model that strengthens the Group’s international competitiveness.
From WHX Dubai to global markets: supporting medical device innovation worldwide
WHX Dubai 2026 confirmed a clear trend: the global healthcare sector requires industrial partners capable of combining technological innovation, regulatory compliance and international vision.
It is no longer sufficient to manufacture. It is necessary to:
- understand regional markets
- support portfolio scalability
- integrate cybersecurity and AI
- guarantee quality, certifications and long-term sustainability
In this scenario, Elemaster positions itself not merely as a supplier, but as an enabler of global technological growth.
Participation in WHX was therefore not an endpoint, but one element of a broader journey: positioning at the frontiers of medical innovation to support customers and partners towards an increasingly digital, secure and scalable future.